(NEW YORK) -- Early in the COVID-19 pandemic, the prevailing theory was that if someone was infected with the virus, they were immune -- at least for a while. But a growing number of Americans seem to be contracting the virus more than once. A recent... Read More.
(NEW YORK) -- For the first time since May, COVID-19-related hospital admissions are forecasted to increase again in the U.S., as highly infectious omicron subvariants continue to spread, according to updated forecasting models used by the Centers for Disease Control and Prevention. The models show... Read More.
(NEW YORK) -- Health officials are once again raising the alarm about the threat of a resurgence of COVID-19 infections across the country, as concerns grow about the new omicron subvariant, BA.5, which is now the dominant viral strain in the U.S. The BA.5 variant,... Read More.
(NEW YORK) -- A new study finds that as the coronavirus continues to evolve, each new omicron subvariant is increasingly likely to lead to reinfection or breakthrough infection. However, researchers say current vaccines are still doing a good job of protecting people against severe... Read More.
(NEW YORK) -- From the onset of the COVID-19 pandemic, the elderly have borne the brunt of the virus’ deadly wrath. Now, newly updated federal data shows that despite widespread vaccination among seniors, virus death rates among older Americans surged to near-record levels during the... Read More.
(NEW YORK) -- In long-awaited data, Pfizer said its 3-dose vaccine was 80% effective against symptomatic omicron COVID-19 infection among children 6 months to under 5 years old. The company cautioned that estimate was preliminary and could be adjusted as more data is collected. The... Read More.
(ATLANTA) -- A new CDC analysis estimates that at least three out of every five Americans have antibodies that indicate a prior COVID-19 infection. Prior to the omicron-fueled surge in cases from December 2021 to February 2022, only an estimated one-third of people in... Read More.
(NEW YORK) -- By this fall, pharmaceutical giant Pfizer and its partner BioNTech could potentially have a COVID-19 booster that specifically addresses the omicron variant as well as its subvariants and other known strains of the virus, CEO Albert Bourla said during a panel... Read More.
(WASHINGTON) -- Nationwide distribution of one of the last remaining monoclonal antibody treatments is being paused "effective immediately" since it has shown to be ineffective against the COVID-19 BA.2 subvariant now dominating every region of the country, an internal letter sent Tuesday afternoon from... Read More.
(ATLANTA) -- The highly contagious omicron subvariant BA.2 is now the dominant COVID-19 strain in the United States, according to data released by the Centers for Disease Control and Prevention on Tuesday. As of March 26, BA.2 is projected to account for nearly 55% of... Read More.